More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%, continuing the medical device company's streak of double-digit sales growth. Sales of its Peri-Strips for gastric bypass surgery, the biggest contributor to its top line, climbed 28%. Yesterday, SYNO agreed to be acquired by Baxter (BAX) for $28/share.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs